Loading clinical trials...
Loading clinical trials...
The goal of this study is to determine the effectiveness and safety of an annual intravenous treatment of zoledronic acid for the treatment of osteoporosis in men. All patients will receive calcium and vitamin D supplements.
Age
25 - 85 years
Sex
MALE
Healthy Volunteers
No
Catalina Pointe Clinical Research Inc.
Tucson, Arizona, United States
Diablo Clinical Research
Walnut Creek, California, United States
Colorado Center for Bone Research
Lakewood, Colorado, United States
Radiant Research
Stuart, Florida, United States
United Osteoporosis Center
Gainesville, Georgia, United States
Northwestern Center for Clinical Research
Chicago, Illinois, United States
Mercy Arthritis and Osteoporosis Center
Des Moines, Iowa, United States
St. Joseph Hospital
Bangor, Maine, United States
Osteoporosis and Clinical Trials Center
Hagerstown, Maryland, United States
New Mexico Clinical Research and Osteoporosis Center
Albuquerque, New Mexico, United States
Start Date
April 1, 2004
Primary Completion Date
August 1, 2007
Completion Date
August 1, 2007
Last Updated
April 27, 2012
288
Estimated participants
Zoledronic Acid
DRUG
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05913219